Johnson & Johnson

Johnson & Johnson is an American multinational healthcare corporation and one of the world's largest pharmaceutical companies, operating its pharmaceutical business through the Janssen subsidiary. Through Janssen, J&J developed and commercialized esketamine nasal spray (Spravato), which received FDA approval in 2019 as the first rapid-acting antidepressant approved in decades.